Electronic clinical outcome assessment (eCOA) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing at a CAGR of 16.4% in the forecast period of 2020 to 2027 and expected to reach USD 534.02 million by 2027. Growing digitization and transformation of infrastructure in the growing number of clinical trials in Asia-Pacific countries is boosting the market growth in the region. Asia-Pacific region is growing due to large population with prevalence of varied diseases. Electronic clinical outcome assessment (eCOA) is dominating in the region as the adoption of emerging technologies is observed to be gaining momentum in certain countries in the region.
The major players covered in the report are Oracle, ERT Clinical, IBM Corporation, eClinical Solutions LLC, Signant Health, Medidata, Omnicomm Systems, Inc., YPrime, LLC among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Get Sample Copy Of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-electronic-clinical-outcome-assessment-ecoa-market
Features mentioned in the report
Changing market dynamics of the industry
To get a comprehensive overview of the Electronic clinical outcome assessment market.
Historical, current and projected market size in terms of volume and value
In-depth market segmentation
In October, 2019, Parexel International Corporation announced collaboration with the Society for Clinical Research Sites (SCRS). Parexel International Corporation operated as the as site engagement and offered services to represent the interest in clinical research sites.
In September 2019, Oracle announced collaboration with Box to enable users to link their cloud and on-premises Oracle and third-party claims with Box via Oracle Integration. This solution is expected to resolve the problems of companies facing interoperability issues with cloud and on-premise solutions.
Asia-Pacific Electronic Clinical Outcome Assessment (eCOA) Market Scope and Market Size
Asia-Pacific electronic clinical outcome assessment (eCOA) market is segmented on the basis of product, approach, end user and platform. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
On the basis of product, the market is segmented into on-premise solutions, cloud based solutions and web based solutions. In Asia-Pacific, the on-premise solutions segment is dominating as they offer full control over updating the application to IT administrators who are not subjected to vendor timelines for maintenance and updates.
On the basis of approach, the market is segmented into clinician reported outcome assessment (CLINRO), patient reported outcome assessment (PRO), observer reported outcome assessment (OBSRO) and performance outcome assessment (PERFO). In Asia-Pacific, clinician reported outcome assessment (CLINRO) is dominating as it is easier to train healthcare professionals to operate new technologies as compared to patients.
On the basis of end user, the market is segmented into commercial service providers, hospitals and transplant centers and research laboratories and academic institutions. In Asia-Pacific, commercial service providers are dominating as it provides access to capabilities and facilities at convenience that might not be accessible or affordable for pharmaceutical companies or any other sponsor.
On the basis of platform, the market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, medical device manufacturers, hospitals and clinical laboratories, consulting service companies, research and academia and others. In Asia-Pacific, contract research organizations are dominating in the market as they promote growth of the companies that are in need of clinical trials.
Get Full Table Of content @ https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-electronic-clinical-outcome-assessment-ecoa-market
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected]
. We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: [email protected]